ESMO® 2026 Highlights: Presenter Vignettes – Daniel Khalaf

Dr. Daniel Khalaf

Daniel Khalaf

MD

Sunnybrook Odette Cancer Centre

2221RO

Patient Reported Quality of Life (QoL) for Docetaxel (Doc) vs Lutetium177-617-PSMA (LuP) for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Results from the Canadian Cancer Trials Group (CCTG) PR21 Trial